These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 25056569)
1. Broad-spectrum micronutrient treatment for attention-deficit/hyperactivity disorder: rationale and evidence to date. Rucklidge JJ; Kaplan BJ CNS Drugs; 2014 Sep; 28(9):775-85. PubMed ID: 25056569 [TBL] [Abstract][Full Text] [Related]
2. Nutrient supplementation approaches in the treatment of ADHD. Rucklidge JJ; Johnstone J; Kaplan BJ Expert Rev Neurother; 2009 Apr; 9(4):461-76. PubMed ID: 19344299 [TBL] [Abstract][Full Text] [Related]
3. Mineral-Vitamin Treatment Associated with Remission in Attention-Deficit/Hyperactivity Disorder Symptoms and Related Problems: 1-Year Naturalistic Outcomes of a 10-Week Randomized Placebo-Controlled Trial. Darling KA; Eggleston MJF; Retallick-Brown H; Rucklidge JJ J Child Adolesc Psychopharmacol; 2019 Nov; 29(9):688-704. PubMed ID: 31343273 [No Abstract] [Full Text] [Related]
4. Clinically Significant Symptom Reduction in Children with Attention-Deficit/Hyperactivity Disorder Treated with Micronutrients: An Open-Label Reversal Design Study. Gordon HA; Rucklidge JJ; Blampied NM; Johnstone JM J Child Adolesc Psychopharmacol; 2015 Dec; 25(10):783-98. PubMed ID: 26682999 [TBL] [Abstract][Full Text] [Related]
5. Bupropion for attention deficit hyperactivity disorder (ADHD) in adults. Verbeeck W; Bekkering GE; Van den Noortgate W; Kramers C Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009504. PubMed ID: 28965364 [TBL] [Abstract][Full Text] [Related]
6. Moderators of treatment response in adults with ADHD treated with a vitamin-mineral supplement. Rucklidge JJ; Johnstone J; Gorman B; Boggis A; Frampton CM Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():163-71. PubMed ID: 24374068 [TBL] [Abstract][Full Text] [Related]
7. An Observational Preliminary Study on the Safety of Long-Term Consumption of Micronutrients for the Treatment of Psychiatric Symptoms. Rucklidge JJ; Eggleston MJF; Ealam B; Beaglehole B; Mulder RT J Altern Complement Med; 2019 Jun; 25(6):613-622. PubMed ID: 31081672 [No Abstract] [Full Text] [Related]
8. Targeting the nicotinic cholinergic system to treat attention-deficit/hyperactivity disorder: rationale and progress to date. Potter AS; Schaubhut G; Shipman M CNS Drugs; 2014 Dec; 28(12):1103-13. PubMed ID: 25349138 [TBL] [Abstract][Full Text] [Related]
9. Database analysis of children and adolescents with bipolar disorder consuming a micronutrient formula. Rucklidge JJ; Gately D; Kaplan BJ BMC Psychiatry; 2010 Sep; 10():74. PubMed ID: 20875144 [TBL] [Abstract][Full Text] [Related]
10. Practitioner Review: Pharmacological treatment of attention-deficit/hyperactivity disorder symptoms in children and youth with autism spectrum disorder: a systematic review and meta-analysis. Rodrigues R; Lai MC; Beswick A; Gorman DA; Anagnostou E; Szatmari P; Anderson KK; Ameis SH J Child Psychol Psychiatry; 2021 Jun; 62(6):680-700. PubMed ID: 32845025 [TBL] [Abstract][Full Text] [Related]
12. Use of Non-Pharmacological Supplementations in Children and Adolescents with Attention Deficit/Hyperactivity Disorder: A Critical Review. Rosi E; Grazioli S; Villa FM; Mauri M; Gazzola E; Pozzi M; Molteni M; Nobile M Nutrients; 2020 May; 12(6):. PubMed ID: 32481502 [TBL] [Abstract][Full Text] [Related]
13. A Systematic Review of the Use of Bupropion for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Ng QX J Child Adolesc Psychopharmacol; 2017 Mar; 27(2):112-116. PubMed ID: 27813651 [TBL] [Abstract][Full Text] [Related]
14. [Atomoxetine: a new treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents]. Purper-Ouakil D; Fourneret P; Wohl M; Rénéric JP Encephale; 2005; 31(3):337-48. PubMed ID: 16142049 [TBL] [Abstract][Full Text] [Related]
15. Cost effectiveness of pharmacotherapies for attention-deficit hyperactivity disorder: a systematic literature review. Wu EQ; Hodgkins P; Ben-Hamadi R; Setyawan J; Xie J; Sikirica V; Du EX; Yan SY; Erder MH CNS Drugs; 2012 Jul; 26(7):581-600. PubMed ID: 22712698 [TBL] [Abstract][Full Text] [Related]
16. Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults. Castells X; Blanco-Silvente L; Cunill R Cochrane Database Syst Rev; 2018 Aug; 8(8):CD007813. PubMed ID: 30091808 [TBL] [Abstract][Full Text] [Related]
17. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes. Faraone SV; Glatt SJ J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220 [TBL] [Abstract][Full Text] [Related]
18. The pharmacological and non-pharmacological treatment of attention deficit hyperactivity disorder in children and adolescents: A systematic review with network meta-analyses of randomised trials. Catalá-López F; Hutton B; Núñez-Beltrán A; Page MJ; Ridao M; Macías Saint-Gerons D; Catalá MA; Tabarés-Seisdedos R; Moher D PLoS One; 2017; 12(7):e0180355. PubMed ID: 28700715 [TBL] [Abstract][Full Text] [Related]
19. Practical considerations for the evaluation and management of Attention Deficit Hyperactivity Disorder (ADHD) in adults. Weibel S; Menard O; Ionita A; Boumendjel M; Cabelguen C; Kraemer C; Micoulaud-Franchi JA; Bioulac S; Perroud N; Sauvaget A; Carton L; Gachet M; Lopez R Encephale; 2020 Feb; 46(1):30-40. PubMed ID: 31610922 [TBL] [Abstract][Full Text] [Related]
20. Successful treatment of bipolar disorder II and ADHD with a micronutrient formula: a case study. Rucklidge JJ; Harrison R CNS Spectr; 2010 May; 15(5):289-95. PubMed ID: 20448519 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]